315 related articles for article (PubMed ID: 26047945)
21. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
[TBL] [Abstract][Full Text] [Related]
22. Stem cells and mammary cancer in mice.
Smith GH
Stem Cell Rev; 2005; 1(3):215-23. PubMed ID: 17142858
[TBL] [Abstract][Full Text] [Related]
23. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
[TBL] [Abstract][Full Text] [Related]
24. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
25. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
26. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.
Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J
Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285
[TBL] [Abstract][Full Text] [Related]
27. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Gonzalez-Suarez E; Jacob AP; Jones J; Miller R; Roudier-Meyer MP; Erwert R; Pinkas J; Branstetter D; Dougall WC
Nature; 2010 Nov; 468(7320):103-7. PubMed ID: 20881963
[TBL] [Abstract][Full Text] [Related]
28. Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.
Steiner JL; Davis JM; McClellan JL; Guglielmotti A; Murphy EA
Cytokine; 2014 Mar; 66(1):60-8. PubMed ID: 24548426
[TBL] [Abstract][Full Text] [Related]
29. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.
Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH
Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155
[TBL] [Abstract][Full Text] [Related]
30. Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells.
Boyle ST; Gieniec KA; Gregor CE; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2017 Jan; 16(1):19. PubMed ID: 28137279
[TBL] [Abstract][Full Text] [Related]
31. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models.
Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W
PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528
[TBL] [Abstract][Full Text] [Related]
32. Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model.
Ma J; Lanza DG; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
Tumour Biol; 2012 Dec; 33(6):1983-96. PubMed ID: 22878936
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence-Activated Cell Sorting of Murine Mammary Cancer Stem-Like Cell Subpopulations with HIF Activity.
Brooks DL; Seagroves TN
Methods Mol Biol; 2018; 1742():247-263. PubMed ID: 29330806
[TBL] [Abstract][Full Text] [Related]
34. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
[TBL] [Abstract][Full Text] [Related]
35. SK4 channels modulate Ca
Steudel FA; Mohr CJ; Stegen B; Nguyen HY; Barnert A; Steinle M; Beer-Hammer S; Koch P; Lo WY; Schroth W; Hoppe R; Brauch H; Ruth P; Huber SM; Lukowski R
Mol Oncol; 2017 Sep; 11(9):1172-1188. PubMed ID: 28557306
[TBL] [Abstract][Full Text] [Related]
36. Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.
Attalla S; Taifour T; Bui T; Muller W
Oncogene; 2021 Jan; 40(3):475-491. PubMed ID: 33235291
[TBL] [Abstract][Full Text] [Related]
37. Dietary Selenium Supplementation Does Not Attenuate Mammary Tumorigenesis-Mediated Bone Loss in Male MMTV-PyMT Mice.
Yan L; Nielsen FH; Sundaram S; Cao J
Biol Trace Elem Res; 2020 Mar; 194(1):221-227. PubMed ID: 31187394
[TBL] [Abstract][Full Text] [Related]
38. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
39. Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice.
Gil EY; Jo UH; Lee HJ; Kang J; Seo JH; Lee ES; Kim YH; Kim I; Phan-Lai V; Disis ML; Park KH
Breast Cancer Res Treat; 2014 Aug; 147(1):69-80. PubMed ID: 25104444
[TBL] [Abstract][Full Text] [Related]
40. PTEN PDZ-binding domain suppresses mammary carcinogenesis in the MMTV-PyMT breast cancer model.
Yan M; Wang Y; Wong CW; Or PM; Wong KL; Li L; Many AM; Guan H; Khoo US; Chan AM
Cancer Lett; 2018 Aug; 430():67-78. PubMed ID: 29772266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
